Cardiovascular manifestations of Lyme disease and effects upon left ventricular dysfunction;Kardiale manifestationen der Lyme-Borreliose unter besonderer berucksichtigung kontraktiler dysfunktion

Acta Medica Austriaca

Volumn 25, Issue 2, 1998, Pages 44-50

  Seinost, G ^b   Gasser, R ^a   Reisinger, E ^a   Rigler, M Y ^a   Fischer, L ^a   Keplinger, A ^a   Dattwyler, R J ^b   Dunn, J J ^c   Klein, W ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b STONY BROOK UNIVERSITY   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Antibiotics; Borrelia burgdorferi; Ceftriaxone; Dilated cardiomyopathy; Lyme disease

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ANTIBIOTIC THERAPY; ARTHRITIS; ARTICLE; BORRELIA BURGDORFERI; CLINICAL ARTICLE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CATHETERIZATION; HEART DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HUMAN; IMMUNOBLOTTING; LYME DISEASE; MALE; NEUROPATHY;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; CEFTRIAXONE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMANS; INFUSIONS, INTRAVENOUS; LYME DISEASE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0031825842     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Bryceson ADM: Clinical pathology of the Jarisch-Herxheimer reaction. J Inf Dis 1966;133:696-703.
2. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP: Lyme disease: Tick borne spirochetosis? Science 1982;216:1317-1319.
3. Burgdorfer W: Lyme borreliosis: ten years after discovery of the etiologic agent, Borrelia burgdorferi. Infection 1991;19:257-267.
4. Christenson VD, White DH: Evaluation of four commercially available ELISA assay for the serologic diagnosis of Lyme disease. J Clin Lab Anal 1991;5:340-343.
5. Corpuz M, Hilton E, Lardis MP, Singer C, Zolan J: Problems in the use of serologic tests for the diagnosis of Lyme disease. Arch Int Med 1991;151:1837-1840.
6. Cox J, Krajden M: Cardiovascular manifestations of Lyme disease. Am Heart J 1991;122:1449-1455.
7. Criteria Commettee, New York Heart Association Inc. Diseases of the Heart and Blood Vessels. Nomenclature and Criteria for Diagnosis. 6th ed. Boston, Little, Brown, 1964.
8. Dattwyler RJ, Halpern JJ, Pass H, Luft BJ: Ceftriaxone as effective therapy in refractory Lyme disease. J Infect Dis 1987;155:1322-1325.
9. Dattwyler RJ, Halpern JJ, Volkman DJ, Luft BJ: Treatment of late Lyme borreliosis randomised comparison of ceftriaxone and penicillin. Lancet 1988;1: 1191-1194.
10. Dec GW, Palacios IF, Fallon JT, Aretz T, Mills J, Lee DC-S, Johnson RA: Active myocarditis in the spectrum of acute dilated cardiomyopathies: Clinical features, histologic correlates and clinical outcome. N Engl J Med 1985;312: 885-890.
11. Dusleag J, Klein W, Eber B, Gasser R, Brussee H, Rotman B, M Grisold: Frequency of magnetic resonance signal abnormalities of the brain in patients aged < 50 years with idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1446-1450.
12. st International Symposium on heart failure-mechanism and management. Abstractbook, 304.
13. Dusleag J, Klein W, Luha O, Fruhwald F, Gasser R, Grisold M, Rotman B, Pokan R: Comparison of the left ventricular cineangiography, echocardiographic semiautomatic edge detection and 3-dimensional computer reconstruction in the assessment of left ventricular function. Eur Heart J 1992;13 (suppl): 316.
14. Erbel R, Schweizer P, Lamberts H, Henn G, Meyer J, Krebs W, Effert S: Echoventriculography. A simultaneous analysis of two-dimensional echocardiography and cineventriculography. Circulation 1983;67:205-213.
15. Erbel R, Schweizer P, Meyer J, Grenner H, Krebs W, Effert S: Bestimmung der Volumina und der Ejectionsfraktion des linken Ventrikels aus dem zweidimensionalen Echoicardiogram bei Patienten mit coronarer Herzerkrankung. Z Kardiol 1980;69:52-61.
16. th International Congress on Lyme Borreliosis, Arlington, May 1992, Abstract book.
17. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Freye R: The natural history of dilated cardiomyopathy. Am J Cardiol 1981;47:525-531.
18. Gasser R, Dusleag J, Reisinger E, Stauber R, Feigl B, Grisold M, Brussee H, Pongratz S, Luha O, Klein W: Reversal by ceftriaxone ofdilated cardiomyopathy associated with Borrelia burgdorferi infection in an endemic area. Presented at the 24th Congress of the European Society of Cardiology, August 30th - Sept. 3rd 1992, Barcelona. Eur Heart J 1992;13 (suppl): 200.
19. Gasser R, Dusleag J, Reisinger E, Stauber R, Feigl B, Grisold M, Brussee H, Pongrati S, Luha O, Klein W: Reversibility by ceftriaxone of dilated cardiomyopathy associated with Borrelia burgdorferi infection. Circulation 1992;86:1807.
20. Gasser R, Dusleag J: Oral treatment of late Lyme borreliosis with roxithromycin plus cotrimoxazole. Lancet 1990;336:1189-1190.
21. Gillum RF: Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J 1986;111:752-761.
22. Goodman JL, Jurkovich P, Kodner C, Johnson RC: Persistant cardiac and urinary tract infections with Borrelia burgdorferi in experimentally infected Syrian hamsters. J Clin Microbiol 1991;29:894-896.
23. Guerre A, Quereda C, Escuerdo R, Cobo J, Morchillo R, Murti-Belda P: Serologic diagnosis of Lyme disease. A pending problem. Enferm Infecc Microbiol Clin 1991;9:335-338.
24. Hansen K, Madsen JK: Myocarditis associated with tickborne Borrelia burgdorferi infection. Lancet 1986;1:1323-1324.
25. Hassler D, Ziller L, Haude M, Hufnagel HD, Sonntag HG: Lyme-borreliose in einem europaischen Endemiegebiet. Antikoerperprävalenz und klinisches Spektrum. Dtsch Med Wschr 1992;117:767-774.
26. Horowitz LN: Arrhythmias and sudden death in cardiac failure. Curr Opin Cardiol 1988;3:357-361.
27. Johnson RA, Palacios I: Dilated Cardiomyopathies of the adult. N Eng J Med 1982;307:1051-1119.
28. Johnson RC, Kodner C, Russel M: In vitro and in vivo suscepibility of the Lyme disease spirochete Borrelia burgdorferi to four antimicrobial agents. Antimicrob Agents Chemother 1987;31:164-167.
29. Kaell AT, Volkman DJ, Gorevic PD, Dattwyler RJ: Positive Lyme serology in subacute bacterial endocarditis. A study of four patients. JAMA 1990;264:2916-2918.
30. Klein J, Stanek G, Bittner R, Holzinger C, Glogar D: Lyme borreliosis as a cause of myocarditis and heart muscle disease. Eur Heart J 12 (suppl): D73-D75.
31. Klein W, Goebel R, Brandt D, Maurer E: Effect of nitroglycerin on patients with left heart failure. In Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds): Nitrates III, Cardiovascular effects. Berlin-Heidelberg-New York, Springer, 1981, pp 488-494.
32. Lyme borreliosis: detecting the great imitator. J Am Osteopath Ass 1991; 91:573-574 und 577-578.
33. McAlister HF, Klementowics PT, Andrews C, Fisher JD, Feld M, Furman S: Lyme carditis: an important cause of reversible heart block. Ann Int Med 1989;110:339-345.
34. Ostrov BE, Athreya BH: Lyme disease. Difficulties in diagnosis and management. Ped Clin North Am 1991;38:535-553.
35. Pedersen LM, Friis-Moller A: Late treatment of Lyme arthritis. Lancet 1991;337:241.
36. Pfeffer MA, Vaughan DE, Parisi AF, Pfeffer MA: Effects of left ventricular shape and captopril on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol 1989;63:1167-1172.
37. Rahn DW, Malawista SE: Lyme disease: recommandations for diagnosis and treatment. Ann Int Med 1991;114:472-481.
38. Report of the WHO/ISCF task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44:672-673.
39. Sahn DJ, De Maria A, Kisslo J, Weymann A: The Commettee on M-Mode Standardization of the American Society of Echocardiography. Recommandations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1075.
40. Schwan TG, Karstens RH, Schrumpf ME, Simpson WJ: Changes in antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete, during persistent infection in mice. Can J Microbiol 1991;37:450-454.
41. Schwan TG, Simpson WJ: Diagnosing Lyme disease. Ann Int Med 1991;115:577-578.
42. Shapiro ED: Lyme disease. Curr Op Infect Dis 1990;3:638-642.
43. Stanek G, Klein J, Bittner R, Glogar D: Borrelia burgdorferi as an etiologic agent in chronic heart failure? Scand J Infect Dis 1991;777 (suppl): 85-87.
44. Stanek G, Klein J, Bittner R, Glogar D: Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 1990;322:249-252.
45. Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbone AG, Burgdorfer W, Schmid GP, Johnson E, Malawista SE: The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:733-740.
46. Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, DeSanna ET, Malawista SE: Treatment of early manifestations of Lyme disease. Ann Intern Med 1983;99:22-26.
47. Unverferth DV: Dilated Cardiomyopathy. Monograph. Mount Kisco, New York: Futura Publishing.
48. Van der Linde MR: Lyme carditis: clinical characteristics of 105 cases. Scand J Infect Dis 1991;77 (suppl): 81-84.
49. Vlay SC, Dervan JP, Elias J, Kane PP, Dattwyler R: Ventricular tachycardia associated with Lyme carditis. Am Heart J 1991;121:1558-1560.
50. Von Polenz HA: Lyme-Borreliose - die "neue" Zeckenbißkrankheit. Sicherheit im öffentlichen Dienst. Zeitschrift der kommunalen und staatlichen Unfallversicherung 1989; 1:4-6.
51. Wunderlich E, Graf A, Thess G, Foelske H: Dilated myocardial disease as sequela of chronic Lyme carditis. Z Kardiol 1990;79:599-600.
52. Yuk JH, Nightingale CH, Quintiliani R: Clinical pharmacokinetics of ceftriaxone. Clin Pharmacokinet 1989;17:223-235.